Anji introduces dynamic equity approach to build high-value therapeutic pipeline addressing treatment gaps in metabolic disorders, oncology, neuroscience, and infectious disease Financing proceeds to ...
NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Technology is transforming the financial services industry—shifting paradigms and improving the infrastructure on which many of us rely. From token ...
BOSTON & NEW YORK--(BUSINESS WIRE)--Anji Pharmaceuticals and Population Health Partners today announced that they have entered into a strategic collaboration, bringing together two complementary teams ...
Anji Pharma, a biotech with outposts in China and the U.S., has raised $70 million to continue clinical development of two metabolic disorder drugs and begin work on an oncology pipeline. Discover the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. At just three years old, Anji already has multiple drugs in ...
New York, New York--(Newsfile Corp. - November 22, 2021) - Anji's CharityPool surpasses $200,000 in BNB and ready to revolutionize the charity sector. Technology is transforming the financial services ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results